111 Inc

111 Inc(YI)股票分析

$3.460

0.000 (0.00%)收盤時

Loading chart…
High
3.460
Open
3.600
VWAP
Vol
0.00
Mkt Cap
92.95M
Low
3.460
Amount
0.00
EV/EBITDA, TTM
0.00

111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 3.46
最低
平均
最高

估值指標

The current forward P/E ratio for 111 Inc (YI) is 0.00, compared to its 5-year average forward P/E of 16.13.

Forward P/E

Fair
5Y Average P/E
16.13
Current P/E
0.00
高估
65.66
低估
-33.41

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
2.95
Current EV/EBITDA
0.00
高估
26.77
低估
-20.88

Forward P/S

Fair
5Y Average P/S
0.07
Current P/S
0.04
高估
0.11
低估
0.03

事件時間軸

2026-01-30 (ET)

14:50:00

111 Inc ADR Trading Halted Due to Volatility Trading Pause

2025-02-11 (ET)

07:01:56

111, Inc. regains Nasdaq compliance

2025-01-08 (ET)

04:08:32

111, Inc. announces one-for-twenty ADS ratio change

2024-10-10 (ET)

06:12:51

111, Inc. announces South, Central China fulfillment centers begin operations

2024-09-27 (ET)

17:28:47

111, Inc. discloses Nasdaq listing deficiency notice

資訊

YI FAQ — answered by Alphio AI

111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector (DRUG STORES AND PROPRIETARY STORES industry).

1 analysts cover YI: 1 rate it Buy, 0 Hold and 0 Sell.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始